Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myelodysplastic-Myeloproliferative Diseases × cabozantinib × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Carcinoma, Renal Cell 12 Neoplasm Metastasis 7 Neoplasms 6 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Medullary 4 Breast Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Thyroid Cancer, Papillary 2 Small Cell Lung Carcinoma 2 Recurrence 2 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Astrocytoma 2 Adenoma, Islet Cell 2 Adenocarcinoma, Follicular 2 Adenocarcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Peripheral Blood Stem Cell Transplantation 12 Whole-Body Irradiation 11 Busulfan 11 Mycophenolic Acid 10 Tacrolimus 9 Methotrexate 8 Cyclosporine 8 Antilymphocyte Serum 8 Etoposide 7 Melphalan 5 Cytarabine 5 Cyclosporins 5 Sirolimus 4 Radiotherapy 4 Rituximab 3 Filgrastim 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 ruxolitinib 2 Granulocyte Colony-Stimulating Factor 2 Flow Cytometry 2 Carmustine 2 Carboplatin 2 veliparib 1 vatalanib 1 treosulfan 1 sargramostim 1 rasburicase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡